Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lymphoma, T-Cell, Peripheral × 10-propargyl-10-deazaaminopterin × Clear all

Phase

Phase 3 7 Phase 2 3 Phase 1/2 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1 Disease Progression 1

Interventions

VAP-cyclo protocol 2 Gemcitabine 2 apatinib 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Lenalidomide 1 Ifosfamide 1 Etoposide 1 Dexamethasone 1 Cisplatin 1 Asparaginase 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03150602 2017-05-12

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Taiwan Mundipharma Pharmaceuticals Ltd.

Phase 4 Unknown

Lymphoma, T-Cell, Peripheral, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡